How Does Genetics Affect Antioxidant Capacity? A Complete Guide

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on longevity and healthy aging. Browse all Longevity & Telomeres education

When people ask about antioxidant capacity, the conversation almost always turns to diet — blueberries, vitamins C and E, polyphenol-rich foods. What it almost never turns to is the question beneath the question: why does equivalent antioxidant intake produce such different biological outcomes in different people? The answer is genetics. Antioxidant capacity — the body's actual functional ability to neutralize reactive oxygen species, recycle oxidized antioxidant molecules, and mount a transcriptional stress response when oxidative load increases — is determined by the genetically set activity levels of five overlapping enzyme systems, each governed by its own variant landscape. The PlexusDx Precision Peptide Genetic Test maps this genetic architecture across 14 pathways, 49 peptides, and 150+ genetic insights, giving providers and patients the antioxidant genetic picture that no dietary assessment and no blood antioxidant panel can deliver.

The Five Antioxidant Systems — and Why Each Is Genetically Variable

The body's antioxidant defense is organized in sequential, interdependent layers. Each layer targets a different reactive oxygen species at a different subcellular location — and each is governed by genetically variable enzymes:

Layer 1 — Superoxide dismutation (SOD1, SOD2, SOD3). Superoxide (O₂•⁻) is the primary ROS produced by electron leakage from the mitochondrial electron transport chain and by NADPH oxidase in immune cells. Superoxide dismutases convert O₂•⁻ to hydrogen peroxide (H₂O₂) — a less reactive but membrane-permeable oxidant that must then be cleared by Layer 2 enzymes. Without adequate SOD activity, superoxide accumulates and reacts with NO to form peroxynitrite (ONOO⁻), one of the most damaging biological oxidants, which directly nitrates proteins and lipids and uncouples eNOS.

Layer 2 — Hydrogen peroxide clearance (GPX, CAT, PRDX). H₂O₂ produced by SOD dismutation is cleared by three enzyme families: glutathione peroxidases (GPX1-8), which use reduced GSH to convert H₂O₂ to water; catalase (CAT), which decomposes H₂O₂ to water and oxygen in peroxisomes; and peroxiredoxins (PRDX1-6), which use thioredoxin as the electron donor to reduce H₂O₂ and lipid hydroperoxides. Inadequate Layer 2 activity allows H₂O₂ to participate in iron-catalyzed Fenton chemistry, generating the hydroxyl radical (•OH) — the most reactive and damaging ROS in biology.

Layer 3 — Glutathione system (GCLC, GCLM, GSR, GSTP1, GSTM1, GSTT1). The glutathione system provides GSH as the electron donor for GPX-mediated H₂O₂ clearance, as the conjugation substrate for GST-mediated detoxification, and as the direct scavenger of lipid radicals and electrophilic compounds. GSR recycles GSSG back to GSH, maintaining the GSH/GSSG ratio that is the primary cellular redox buffer. GCLC and GCLM genetics set the synthesis rate; GSR genetics sets the recycling rate.

Layer 4 — Thioredoxin system (TXNRD1, TXN1, PRDX). Thioredoxin (TXN1) is a small redox protein that accepts electrons from TXNRD1 (thioredoxin reductase, a selenoprotein requiring selenium) and donates them to PRDX enzymes for H₂O₂ clearance, to ribonucleotide reductase for DNA synthesis, and to oxidized protein thiol groups for protein repair. TXNRD1 genetic variants shape the thioredoxin cycle's electron transfer efficiency — an often-overlooked antioxidant genetic variable that operates independently of the glutathione system.

Layer 5 — Transcriptional antioxidant response (NFE2L2/NRF2, FOXO3). All four enzymatic layers above are transcriptionally regulated by two master longevity transcription factors: NRF2 (encoded by NFE2L2) through antioxidant response elements (AREs), and FOXO3 through forkhead response elements (FHREs). When oxidative stress is detected, NRF2 and FOXO3 activate the transcription of hundreds of antioxidant, detoxification, and stress response genes — amplifying enzyme expression across all four enzymatic layers simultaneously. The genetic capacity for this transcriptional stress response determines how effectively the biological system scales up its antioxidant output when demand increases.

Layer 1 Genetics: SOD2 Val16Ala and the Mitochondrial Superoxide Baseline

The most functionally significant superoxide dismutase variant for longevity is SOD2 Val16Ala (rs4880) — a C→T transversion in the SOD2 mitochondrial targeting sequence that substitutes alanine for valine at position 16 of the mature protein. The Val16 (C) allele produces a more efficiently imported SOD2 enzyme — the alpha-helical targeting sequence better engages the mitochondrial import machinery, delivering more SOD2 to the mitochondrial matrix where electron transport chain superoxide is generated. Ala16 (T) allele carriers produce SOD2 with a beta-sheet targeting sequence that imports less efficiently — reducing mitochondrial SOD2 density and activity per unit of SOD2 mRNA.

Published studies comparing Val/Val and Ala/Ala SOD2 carriers show Val/Val individuals have higher mitochondrial SOD2 activity, lower mitochondrial superoxide steady-state concentrations, less mitochondrial oxidative DNA damage, and — in multiple longevity cohort studies — greater representation at extreme old age. The effect size is modest in healthy young adults with intact antioxidant redundancy but becomes progressively more consequential as age-related antioxidant decline removes the buffering capacity that compensates for lower SOD2 baseline activity in Ala/Ala individuals.

The SOD2 × eNOS interaction is particularly important: when mitochondrial superoxide levels are elevated from low SOD2 activity, superoxide reacts with the NO produced by eNOS to form peroxynitrite — simultaneously reducing NO bioavailability (impairing vascular function) and creating a potent oxidant that nitrotyrosinates proteins, damages mitochondrial membrane lipids, and contributes to the mtDNA mutation accumulation that characterizes aging mitochondria. Full SOD2 detail: SOD2 and Oxidative Stress: Your Genetic Antioxidant Defense.

Layer 2 Genetics: GPX1 Pro198Leu and Catalase Variants

GPX1 Pro198Leu (rs1050450) is the primary Layer 2 genetic variable. The Leu198 (T) allele is associated with approximately 30–40% lower GPX1 catalytic efficiency in published enzymatic studies — reducing the rate at which H₂O₂ produced by SOD dismutation is converted to water. Leu/Leu GPX1 individuals clear hydrogen peroxide more slowly, allowing greater steady-state H₂O₂ accumulation and more Fenton-derived hydroxyl radical production at equivalent SOD2 superoxide output.

The SOD2 × GPX1 compound genotype is the most important Layer 1 × Layer 2 interaction in antioxidant genetics: Val/Val SOD2 (efficient superoxide dismutation) + Pro/Pro GPX1 (efficient H₂O₂ clearance) produces the most complete antioxidant protection across the two-step O₂•⁻ → H₂O₂ → H₂O cascade. Ala/Ala SOD2 (reduced superoxide dismutation) + Leu/Leu GPX1 (reduced H₂O₂ clearance) represents the compound genotype with the greatest mitochondrial ROS accumulation — both from the primary superoxide that accumulates from reduced SOD2 dismutation and from the secondary H₂O₂ that accumulates from reduced GPX1 clearance.

Catalase (CAT) variants — particularly the C-262T promoter polymorphism (rs1001179) — affect CAT expression in hepatic and erythrocyte tissue, with the T allele associated with lower CAT transcriptional activity and reduced erythrocyte catalase levels in published studies. Because catalase and GPX1 share the same H₂O₂ substrate, CAT promoter variants compound GPX1 Pro198Leu effects — both reduce H₂O₂ clearance, but through independent enzymatic systems whose combined genetic insufficiency is more consequential than either alone.

Layer 3 Genetics: The Glutathione System Baseline

The genetic architecture of the glutathione system — GCLC (rate-limiting synthesis), GCLM (synthesis efficiency), GSR (GSSG recycling), GPX1 (GSH-dependent H₂O₂ clearance), and GSTM1/GSTT1 (conjugation capacity) — is detailed in full in What Genes Affect Glutathione Production? In the antioxidant capacity framework, the glutathione system functions as:

The electron source for Layer 2 GPX reactions — GSH donates electrons to GPX1 for H₂O₂ reduction, generating GSSG that GSR must recycle. GCLC synthesis rate and GSR recycling rate together determine the sustained GSH availability under oxidative load — the rate-limiting factors for the GPX-mediated H₂O₂ clearance component of Layer 2 capacity.

The primary buffer against lipid peroxidation — GSH directly scavenges lipid radicals generated when hydroxyl radicals attack polyunsaturated fatty acids in cell membranes, interrupting the lipid peroxidation chain reaction. GPX4 (phospholipid hydroperoxide GPX) specifically reduces phospholipid hydroperoxides in membranes using GSH — and GPX4 activity is the primary defense against ferroptosis (iron-dependent oxidative cell death), a cell death pathway increasingly implicated in aging tissue degeneration.

The substrate for xenobiotic and endogenous electrophile conjugation — GSTM1 and GSTT1 consume GSH to conjugate electrophilic metabolites, providing a parallel demand on GSH pools that competes with peroxidase and radical scavenging functions under high toxicant or metabolic stress.

Layer 4 Genetics: The Thioredoxin System

The thioredoxin system operates in parallel with the glutathione system — providing a second electron donor pathway for peroxiredoxin-mediated H₂O₂ clearance and a distinct protein thiol repair capacity that the glutathione system cannot substitute for. TXNRD1 (thioredoxin reductase 1) is a selenoprotein — like GPX1, it requires dietary selenium for its active site selenocysteine. TXNRD1 variants affecting enzyme expression or catalytic efficiency, combined with selenium nutritional status, determine the thioredoxin cycle's contribution to total cellular antioxidant capacity.

The thioredoxin system's most critical non-redundant function is protein thiol reduction — restoring oxidized cysteine residues in proteins to their reduced, functional state. Many transcription factors — including NRF2 itself — require reduced thiol groups in their DNA-binding domains for activity. Impaired thioredoxin system function therefore has a compounding effect: not only does it reduce direct peroxiredoxin-mediated ROS clearance, it impairs the activity of the very transcription factors that would upregulate antioxidant gene expression in response to the oxidative stress that thioredoxin deficiency allows to accumulate.

Layer 5 Genetics: NFE2L2 and FOXO3 as the Transcriptional Amplifiers

The most consequential antioxidant genetic variable is not any individual enzyme variant — it is the genetic capacity of the transcriptional response system to detect oxidative stress and scale up the enzymatic antioxidant response. This transcriptional amplification capacity is governed by two master regulators:

NFE2L2 (NRF2) promoter variants — the -617C/A, -651G/A, and -653A/G haplotypes that reduce NRF2 basal transcription — produce less NRF2 protein available for nuclear translocation when oxidative stress is detected. Less nuclear NRF2 → less ARE-driven transcription → smaller induction of GCLC, GCLM, GSR, GPX1, TXNRD1, and the broader antioxidant gene set in response to oxidative challenge. The low-NRF2 haplotype produces a system where basal antioxidant enzyme expression is lower and stress-induced amplification is blunted simultaneously — the most consequential antioxidant genetic deficit for individuals facing high oxidative loads.

FOXO3 rs2802292 — the T allele associated with lower FOXO3 expression — reduces the FOXO3-driven antioxidant gene transcription that operates independently of NRF2 through FHREs. FOXO3 specifically drives SOD2, catalase, and GADD45A expression in response to oxidative stress — making FOXO3 genetics a Layer 1 (SOD2), Layer 2 (catalase), and DNA repair amplifier that compounds with NFE2L2 genetics at the transcriptional layer above all enzymatic variants. Full FOXO3 detail: Does FOXO3 Affect How You Age?

The NFE2L2 × FOXO3 compound transcriptional genotype produces the widest range of antioxidant stress response capacity in the human population — from individuals with high-activity NFE2L2 promoters and G/G FOXO3 (most robust stress-induced antioxidant amplification) to individuals with low-activity NFE2L2 promoters and T/T FOXO3 (most attenuated). Under low oxidative stress conditions, the enzymatic baseline variants (SOD2, GPX1, GCLC) dominate. Under high oxidative stress — aging, inflammation, environmental toxicant exposure, metabolic syndrome — the transcriptional amplification capacity of NFE2L2 and FOXO3 becomes the primary determinant of whether the biological system can scale its antioxidant response to meet the challenge.

How Antioxidant Genetics Interacts With Lifestyle

Understanding antioxidant genetics changes the personalization framework for oxidative stress management in three specific ways:

It identifies which system is the primary genetic bottleneck. Low SOD2 Val16Ala activity points toward mitochondrial superoxide accumulation as the primary source — interventions supporting mitochondrial SOD2 activity (aerobic exercise, which upregulates SOD2 expression; MnSOD cofactor Mn²⁺ adequacy; reduced mtETC electron leak through metabolic health optimization) are most relevant. Low GPX1 Pro198Leu activity combined with low GCLC synthesis genetics points toward H₂O₂ clearance and GSH availability as compounding bottlenecks — selenium optimization (for GPX1 selenocysteine), active folate and B12 support (for cysteine transsulfuration supply to GCLC), and N-acetylcysteine (direct cysteine supplementation for GSH synthesis) are most relevant.

It identifies when transcriptional amplification capacity is the limiting variable. Low-activity NFE2L2 + T/T FOXO3 individuals have genetically attenuated stress-induced antioxidant amplification — meaning their enzymatic antioxidant baseline is harder to scale up under oxidative challenge. For these individuals, compounds and lifestyle inputs that activate NRF2 (sulforaphane from cruciferous vegetables, Nrf2-activating polyphenols) and FOXO3 (caloric restriction, intermittent fasting, exercise, insulin sensitivity optimization) are most pharmacodynamically relevant.

It contextualizes why antioxidant supplementation response varies. Individuals with low GCLC genetics receive more benefit from NAC or glycine supplementation (boosting GSH synthesis substrate) than those with adequate GCLC function. Individuals with low GPX1 activity receive more benefit from selenium optimization than those with Pro/Pro GPX1 function — because the selenium cofactor is rate-limiting for their genetically constrained enzyme, rather than simply supplementing already-adequate selenoprotein activity.

The complete longevity panel framework — how antioxidant genetics integrates with NAD+ biology, telomere maintenance, mitochondrial function, and methylation — is in the Complete Guide to Genetic Longevity Testing.

The Precision Peptide Genetic Test analyzes how your genes influence longevity and aging pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to map your antioxidant genetic architecture across all five systems? Take the Precision Peptide Genetic Test

Frequently Asked Questions About Genetics and Antioxidant Capacity

Which genes most affect antioxidant capacity?

SOD2 (Val16Ala rs4880) governs mitochondrial superoxide dismutation; GPX1 (Pro198Leu rs1050450) governs H₂O₂ clearance; GCLC and GCLM govern glutathione synthesis rate; and NFE2L2/NRF2 and FOXO3 govern the transcriptional stress response that amplifies all enzymatic systems simultaneously. The Precision Peptide Genetic Test maps all five antioxidant system layers within 14 pathways and 150+ genetic insights.

Why do people with similar diets have different antioxidant protection?

Dietary antioxidants support but cannot substitute for genetically variable enzymatic systems. SOD2 Val16Ala determines mitochondrial superoxide dismutation regardless of vitamin E intake. GPX1 Pro198Leu determines H₂O₂ clearance regardless of vitamin C intake. GCLC variants determine glutathione synthesis rate regardless of polyphenol consumption. The Precision Peptide Genetic Test maps these variants within 14 pathways, 150+ insights.

How does antioxidant genetic insufficiency connect to aging?

Antioxidant genetic insufficiency allows ROS accumulation driving three aging hallmarks: mitochondrial DNA mutation (from hydroxyl radical damage), epigenetic clock acceleration (from oxidative CpG demethylation), and telomere attrition (from oxidative strand breaks preferentially targeting G-rich telomeric sequences). The Precision Peptide Genetic Test maps these genetic variables within 14 pathways and 150+ genetic insights.

This article is part of the PlexusDx Education Hub. Browse all Longevity & Telomeres education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.